Syngene International

Syngene International announced a leadership change on July 2, 2026. Syngene International said Siddharth Mittal, formerly Managing Director and CEO of Biocon, succeeded Peter Bains as Managing Director and CEO, with a stated priority of sharpening the company’s commercial edge and restoring growth momentum.

What changed

Siddharth Mittal was named Managing Director and Chief Executive Officer. Peter Bains completed his tenure as Managing Director and CEO on June 30, 2026, and Mittal succeeded him.

• Leader: Siddharth Mittal
• Role: Managing Director and Chief Executive Officer
• Effective: July 1, 2026
• Announcement date: July 2, 2026

Leadership background

Mittal brings close to three decades of business leadership experience, the company said. He joined Syngene from Biocon Limited, where he most recently served as Managing Director and CEO after holding the position of Chief Financial Officer during his thirteen years there. Syngene said he played a pivotal role in shaping Biocon’s strategic direction and in commercializing its GLP-1 portfolio across major international markets.

The mandate

Mittal said his immediate priority is to sharpen the company’s commercial edge, strengthen delivery excellence, and bring greater focus and discipline to execution across the business. He said he is confident the company can restore growth momentum, reinforce Syngene’s standing as a global leader in CRDMO services, and create long-term value for all its stakeholders.

Why this matters for GTM teams

Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.

Source and methodology

This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.

Primary source: Syngene International leadership announcement.